Things To Watch For In Japan In 2015
This article was originally published in PharmAsia News
Tax changes and policy evolution in the pricing and regulatory areas are some of the events set to shape Japan's pharma operating environment in 2015, as PharmAsiaNews does some crystal ball gazing for the year ahead.
You may also be interested in...
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.